President Joe Biden‘s nominee to lead the National Institute of Health, Dr. Fauci’s former post, has allegedly received MILLIONS of dollars from Big Pharma – SHOCKER!
The American Accountability Foundation, a conservative watchdog group has discovered that Biden-nominee Dr. Monica Bertagnolli has “problematic close ties with big pharma.”
“Big Pharma bankrolled her career, and she has long been a friend and ally to them,” the group revealed to the New York Post.
“Especially after the corruption and lies that came from the government’s medical agencies during COVID, the American people need to know that NIH will be led by honest people who serve them, and are not owned by massive corporations.”
“Our government’s medical institutions must serve the interests of the American people, not Big Pharma,” the group said. “However, Dr. Bertagnolli’s extensive financial ties to pharmaceutical companies raise serious questions about her ability to lead NIH in a manner that is not beholden to special or secret interests.”
The 64-year-old Bertagnolli has received more than $350 million in research-related funds from the biggest names in the pharmaceutical industry – including at least $56 million from Pfizer, Seagan Inc., and AstraZeneca Pharmaceuticals in 2022 ALONE.
After Dr. Fauci’s reign as head of the NIH came to an end only AFTER he had sold the American people out to Big Pharma. It’s rather disturbing that Joe Biden has chosen someone to replace Fauci with someone who is even MORE closely linked to Big Pharma.
Part of that $350 million in funding included grants awarded to a non-profit group ran by Bertagnolli which conducted nationwide clinical trials on cancer prevention where, as the watchdog group suggests, Bertagnolli likely had secondary funds “flowed through to her salary at [Boston’s] Brigham and Women’s Hospital/Dana Farber Cancer Institute where she is a researcher.”
According to the 2022-2023 financial disclosure forms included in the report, Bertagnolli reported $1,609,198 in salary and bonuses just from the cancer institute.
Meanwhile, Joe Biden announced Bertagnolli’s nomination as NIH Director a few months back while calling her a “world-renowned surgical oncologist, cancer researcher, educator, and physician-leader who has the vision and leadership needed to deliver on NIH’s mission to seek fundamental knowledge and promote human health.”
But it’s more likely that Bertagnolli will pursue her own mission of using the position of power to enrich herself off of her Big Pharma allies even more!
She’s already sided with Big Pharma over the people during several instances in her career. During the Trump administration, Bertagnolli vocally opposed a proposal by Donald Trump which sought to slash prices of prescription drugs like Insulin by roughly 50%.
“This model, which imposes a nationwide, mandatory experiment without the ability to actually learn whether this is an optimal approach, will drastically cut reimbursement for a number of life-saving cancer drug treatments, significantly limiting access to care for Medicare beneficiaries,” Bertagnolli said.
This woman doesn’t care about the people – she only cares about the bottom line for Big Pharma!